Celularity holder lets $2M note option expire
The Philip & Daniele Barach Family Trust, a 10% owner of Celularity Inc., reported changes in its derivative positions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Philip & Daniele Barach Family Trust, a 10% owner of Celularity Inc., reported changes in its derivative positions. The trust’s option to purchase up to $2,000,000 in convertible notes, which were convertible into 1,807,229 shares of Class A common stock, expired pursuant to its terms on June 19, 2026 without any consideration paid. A related option to obtain up to 839,160 warrants also expired on that date. The filing also lists continuing holdings of warrants and convertible notes that are convertible into 3,707,457 and 1,807,229 shares of Class A common stock, respectively.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Convertible Notes | 1,204,819 | $0.00 | $0.00 |
| Other | Warrants | 839,160 | $0.00 | $0.00 |
| holding | Convertible Notes | -- | -- | -- |
| holding | Warrants | -- | -- | -- |
Footnotes (2)
- F1. Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the "Notes") that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.
- F2. Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the "Warrants") that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date.
Key Figures
Key Terms
Convertible Notes financial
aggregate principal amount financial
Warrants financial
Class A Common Stock financial
option to purchase financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Philip & Daniele Barach Family Trust report in the Celularity (CELU) Form 4?
How large was the Celularity (CELU) convertible note option held by the Barach Family Trust?
What happened to the Celularity (CELU) warrant rights linked to the Barach Family Trust’s notes?
What derivative securities does the Barach Family Trust still hold in Celularity (CELU)?
Did the Barach Family Trust pay or receive consideration when its Celularity (CELU) note option expired?
AI-generated analysis. How Rhea-AI works. Not financial advice.